Allogeneic Stem Cell Transplantation in Patients with β-thalassemia: King Faisal Specialist Hospital and Research Centre Experience

From January 1998–July 2006, 62 stem cell transplantation (SCT) were performed on 60 patients with β-thalassemia from HLA-related match donors. The overall survival (OS) and event free survival (EFS) for all patients were 94 and 77%. The outcome of allogeneic SCT in our experience is satisfactory with OS 92% and EFS 77%. Transplantation at a young age and when the disease is mild offers the best outcome. More advanced disease is associated with higher rate of rejection and severe graft versus host disease.

[1]  A. Mastronuzzi,et al.  Treosulfan‐based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major , 2008, British journal of haematology.

[2]  M. Roncarolo,et al.  Second hematopoietic SCT in patients with thalassemia recurrence following rejection of the first graft , 2008, Bone Marrow Transplantation.

[3]  B. George,et al.  Randomized trial of two different conditioning regimens for bone marrow transplantation in thalassemia – the role of busulfan pharmacokinetics in determining outcome , 2005, Bone Marrow Transplantation.

[4]  M. Freund,et al.  Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation. , 2004, Blood.

[5]  M. Cowan,et al.  Bone Marrow Transplantation for &bgr;-Thalassemia: The University of California San Francisco Experience , 2000, Journal of pediatric hematology/oncology.

[6]  G. Lucarelli,et al.  Bone Marrow Transplantation in Thalassemia: The Experience of Pesaro , 1998, Annals of the New York Academy of Sciences.

[7]  B. Bostrom,et al.  Relationship of plasma pharmacokinetics of high-dose oral busulfan to the outcome of allogeneic bone marrow transplantation in children with thalassemia , 1997, Bone Marrow Transplantation.

[8]  L. Battistini,et al.  Hepatitis C virus infection in thalassemia patients undergoing allogeneic bone marrow transplantation. , 1994, Bone marrow transplantation.

[9]  M. Amylon,et al.  Bone marrow transplantation for thalassemia. The USA experience. , 1994, The American journal of pediatric hematology/oncology.

[10]  M. Andreani,et al.  Influence of the conditioning regimens on the incidence of mixed chimerism in thalassemic transplanted patients. , 1993, Bone marrow transplantation.